Single-cell Analysis of Matrisome-related Genes in Breast Invasive Carcinoma: New Avenues for Molecular Subtyping and Risk Estimation

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Nov 4

PMID 39493752

Authors

Lingzi Su

Zhe Wang

Mengcheng Cai

Qin Wang

Man Wang

Wenxiao Yang

Yabin Gong

Fanfu Fang

Ling Xu

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of breast cancer remains high and severely affects human health. However, given the heterogeneity of tumor cells, identifying additional characteristics of breast cancer cells is essential for accurate treatment.

Purpose: This study aimed to analyze the relevant characteristics of matrix genes in breast cancer through the multigroup data of a breast cancer multi-database.

Methods: The related characteristics of matrix genes in breast cancer were analyzed using multigroup data from the breast cancer multi database in the Cancer Genome Atlas, and the differential genes of breast cancer matrix genes were identified using the elastic net penalty logic regression method. The risk characteristics of matrix genes in breast cancer were determined, and matrix gene expression in different breast cancer cells was evaluated using real-time fluorescent quantitative polymerase chain reaction (PCR). A consensus clustering algorithm was used to identify the biological characteristics of the population based on the matrix molecular subtypes in breast cancer, followed by gene mutation, immune correlation, pathway, and ligand-receptor analyses.

Results: This study reveals the genetic characteristics of cell matrix related to breast cancer. It is found that 18.1% of stromal genes are related to the prognosis of breast cancer, and these genes are mostly concentrated in the biological processes related to metabolism and cytokines in protein. Five different matrix-related molecular subtypes were identified by using the algorithm, and it was found that the five molecular subtypes were obviously different in prognosis, immune infiltration, gene mutation and drug-making gene analysis.

Conclusions: This study involved analyzing the characteristics of cell-matrix genes in breast cancer, guiding the precise prevention and treatment of the disease.

References

Ramilowski J, Goldberg T, Harshbarger J, Kloppmann E, Kloppman E, Lizio M . A draft network of ligand-receptor-mediated multicellular signalling in human. Nat Commun. 2015; 6:7866. PMC: 4525178. DOI: 10.1038/ncomms8866. View

Wang W, Zhao H, Wang S . Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data. Front Immunol. 2023; 14:1099071. PMC: 9922847. DOI: 10.3389/fimmu.2023.1099071. View

Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H . Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008; 14(5):518-27. DOI: 10.1038/nm1764. View

Pal B, Chen Y, Vaillant F, Capaldo B, Joyce R, Song X . A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J. 2021; 40(11):e107333. PMC: 8167363. DOI: 10.15252/embj.2020107333. View

Shao Y, Zheng Z, Li S, Yang G, Qi F, Fei F . Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma. J Oncol. 2022; 2022:5185202. PMC: 9553514. DOI: 10.1155/2022/5185202. View

John C, Watson D, Russ D, Goldmann K, Ehrenstein M, Pitzalis C . M3C: Monte Carlo reference-based consensus clustering. Sci Rep. 2020; 10(1):1816. PMC: 7000518. DOI: 10.1038/s41598-020-58766-1. View

Freire N, da Cunha Jaeger M, de Farias C, Nor C, Souza B, Gregianin L . Targeting the epigenome of cancer stem cells in pediatric nervous system tumors. Mol Cell Biochem. 2023; 478(10):2241-2255. DOI: 10.1007/s11010-022-04655-2. View

Mircetic J, Dietrich A, Paszkowski-Rogacz M, Krause M, Buchholz F . Development of a genetic sensor that eliminates p53 deficient cells. Nat Commun. 2017; 8(1):1463. PMC: 5684360. DOI: 10.1038/s41467-017-01688-w. View

Newman A, Steen C, Liu C, Gentles A, Chaudhuri A, Scherer F . Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019; 37(7):773-782. PMC: 6610714. DOI: 10.1038/s41587-019-0114-2. View

10.

Denais C, Gilbert R, Isermann P, McGregor A, Te Lindert M, Weigelin B . Nuclear envelope rupture and repair during cancer cell migration. Science. 2016; 352(6283):353-8. PMC: 4833568. DOI: 10.1126/science.aad7297. View

11.

Naba A, Clauser K, Hoersch S, Liu H, Carr S, Hynes R . The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. 2011; 11(4):M111.014647. PMC: 3322572. DOI: 10.1074/mcp.M111.014647. View

12.

Barron-Gallardo C, Garcia-Chagollan M, Moran-Mendoza A, Delgadillo-Cristerna R, Martinez-Silva M, Villasenor-Garcia M . A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival. Front Genet. 2022; 13:991706. PMC: 9634254. DOI: 10.3389/fgene.2022.991706. View

13.

Chen J, Li X, Yan S, Li J, Zhou Y, Wu M . An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer. Front Oncol. 2023; 12:929240. PMC: 9798206. DOI: 10.3389/fonc.2022.929240. View

14.

Pu J, Teng Z, Yang W, Zhu P, Zhang T, Zhang D . Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes. Carcinogenesis. 2022; 44(2):143-152. DOI: 10.1093/carcin/bgac098. View

15.

Fukai S, Nakajima S, Saito M, Saito K, Kase K, Nakano H . Down-regulation of stimulator of interferon genes (STING) expression and CD8 T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer. Gastric Cancer. 2023; 26(6):878-890. DOI: 10.1007/s10120-023-01417-x. View

16.

Zhang L, Chen Q, Zong H, Xia Q . Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression. Mol Cell Biochem. 2023; 479(9):2459-2470. DOI: 10.1007/s11010-023-04854-5. View

17.

Denk D, Greten F . Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 2022; 8(11):901-914. DOI: 10.1016/j.trecan.2022.07.002. View

18.

Kao K, Chang K, Hsu H, Huang A . Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer. 2011; 11:143. PMC: 3094326. DOI: 10.1186/1471-2407-11-143. View

19.

Zhang Z, Li H, Jiang S, Li R, Li W, Chen H . A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data. Brief Bioinform. 2018; 20(4):1524-1541. PMC: 6781580. DOI: 10.1093/bib/bby023. View

20.

Calmeiro J, Carrascal M, Tavares A, Ferreira D, Gomes C, Falcao A . Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics. 2020; 12(2). PMC: 7076373. DOI: 10.3390/pharmaceutics12020158. View